| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/28/2001 | EP1086138A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 03/28/2001 | EP1086132A1 Gene encoding organic anion transporter |
| 03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
| 03/28/2001 | EP1085897A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/28/2001 | CN1289369A Riboflavin biosynthesis genes from plants and uses thereof |
| 03/28/2001 | CN1289368A Process for constructing amino acid-producing bacterium and process for producing amino acid by fermentation method with the use of the thus constructed amino acid-producing bacterium |
| 03/28/2001 | CN1289339A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 03/28/2001 | CN1288949A Conditions of culturing deep red saccharomycete to produce phenylalanine deaminase |
| 03/28/2001 | CN1288948A Nutritious yeast salt |
| 03/28/2001 | CN1288947A Screening method for live high-enzyme strain of deep red saccarom ycete |
| 03/28/2001 | CN1063795C Method for production of glucagon |
| 03/28/2001 | CN1063788C Fermenting production process of cordyceps fungus |
| 03/28/2001 | CN1063787C Use of candelabrella SP on farm |
| 03/28/2001 | CN1063786C Production method for iron-rich pure spirulina |
| 03/27/2001 | US6207814 Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them |
| 03/27/2001 | US6207812 Chondrosarcoma associated genes |
| 03/27/2001 | US6207804 Genetically engineered antibody analogues and fusion proteins thereof |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration |
| 03/27/2001 | US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 03/27/2001 | US6207799 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 03/27/2001 | US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma |
| 03/27/2001 | US6207647 Polynucleotides and polypeptides of the rat family, referred to as ?rata?; treatment of chlamydia infections |
| 03/27/2001 | US6207642 Member of the TNF family useful for treatment and diagnosis of disease |
| 03/27/2001 | US6207450 Nucleic acid of defined nucleotide sequence which encodes fkhl7 protein; drug screening; primers; probes; gene therapy; antibodies; recombinant production |
| 03/27/2001 | US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics |
| 03/27/2001 | US6207440 Bacterial strain includes defined nucleotide sequence; fish aquariums; aquaculture |
| 03/27/2001 | US6207435 Method for producing nucleoside-5′-phosphate ester |
| 03/27/2001 | US6207430 Recombinant production; discoloration inhibition in textiles and detergents; polymerization and depolymerization of lignin and derivatives; detoxification of soil; food processing of fruit juice |
| 03/27/2001 | US6207428 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof from the fermentation broth of streptomyces sp. P 6621 FERM P 2804 |
| 03/27/2001 | US6207427 Method for producing optically active compound |
| 03/27/2001 | US6207420 Nucleotide sequences for the transcription and translation of protein with preferential solubility; to prevent inclusion bodies in genetic engineering systems |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/27/2001 | US6207413 Nucleotide sequence coding binding protein; for the diagnosis and treatment of endocrine defects |
| 03/27/2001 | US6207411 Bacteriocins |
| 03/27/2001 | US6207409 Culturing a recombinant cell that has been transformed with an expression vector having a regulatory sequence and a polynucleotide comprising a dna sequence which endcodes geranyl/geranylpyrophosphate of flavobacterium species |
| 03/27/2001 | US6207407 Identification of antibacterial agents |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207390 Incubating target with biotin in mixture, allow biotinylation, incubate heterogenous mix with solid support, incubate with target, monitor preferential binding of avidins |
| 03/27/2001 | US6207386 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 03/27/2001 | US6207383 Adjusted nucleotide sequences associated with genetic disorder; for the diagnosis, treatment and prevention of arrhythmia |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | US6207169 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 03/27/2001 | US6207162 AspS from Chlamydia trachomatis |
| 03/27/2001 | US6207144 Polypeptides with interleukin-16 activity, process for the preparation and use thereof |
| 03/27/2001 | US6207056 Growing microbiological culture in portable apparatus at site of grease trap in presence of organic nutrient chemically similar to waste product, periodically discharging culture into trap to control accumulation of waste product |
| 03/27/2001 | CA2161881C High lysine derivatives of alpha-hordothionin |
| 03/27/2001 | CA2123107C Ubiquitin-specific proteases |
| 03/27/2001 | CA1341211C Mini-proinsulin, its preparation and use |
| 03/27/2001 | CA1341208C Proteins with factor viii activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them |
| 03/24/2001 | CA2283376A1 Synthesis of optically active phenylalanine analogs through microbial transformations |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001020031A2 Polymorphisms in a klotho gene |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/22/2001 | WO2001020025A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | WO2001020016A2 Method for increasing the yield of recombinant proteins in microbial fermentation processes |
| 03/22/2001 | WO2001020013A2 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | WO2001020012A2 Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 03/22/2001 | WO2001020008A2 Vascular-specific promoters |
| 03/22/2001 | WO2001020007A1 A multifunctional system for the efficient manipulation of protein expression in filamentous fungi and method using same |
| 03/22/2001 | WO2001020005A1 Regulatory sequences and expression cassettes for yeasts, especially for kluyveromyces |
| 03/22/2001 | WO2001020004A2 Protein phosphatase and kinase proteins |
| 03/22/2001 | WO2001020003A2 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 03/22/2001 | WO2001020002A1 Thermostable luciferases from photuris pennsylvanica and pyrophorus plagiophthalamus and methods of production |
| 03/22/2001 | WO2001020001A1 Nadph-oxidase thyroid enzyme, nucleic acid coding for same and applications thereof |
| 03/22/2001 | WO2001020000A1 Nucleic acid which is obtained from tetrahymena and which codes for a delta-6-desaturase, the production thereof and use |
| 03/22/2001 | WO2001019998A1 Novel detoxified mutants of escherichia coli heat-labile enterotoxin |
| 03/22/2001 | WO2001019996A1 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
| 03/22/2001 | WO2001019988A1 Secreted proteins and polynucleotides encoding them |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019982A2 Micro-organisms, their use and method for producing d-amino acids |
| 03/22/2001 | WO2001019974A2 Recombinant microorganisms |
| 03/22/2001 | WO2001019973A2 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | WO2001019972A2 Fermentation process with immobilized microorganisms |
| 03/22/2001 | WO2001019963A2 System and method for microwave cell lysing of small samples |
| 03/22/2001 | WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | WO2001019955A2 Lysosomal targeting pathway enzymes |
| 03/22/2001 | WO2001019871A2 Delivery system for antidandruff agent |
| 03/22/2001 | WO2001019868A1 A novel angiogenesis inhibitor |
| 03/22/2001 | WO2001019866A1 Dipeptidyl peptidases |
| 03/22/2001 | WO2001019862A2 Polypeptides from moraxella (branhamella) catarrhalis |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019856A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | WO2001019840A1 Pesticidal macrolides |
| 03/22/2001 | WO2001019542A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 03/22/2001 | WO2001009332A3 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000071693A3 Method for selecting improved vectors |
| 03/22/2001 | WO2000067696A3 Lactic acid bacteria with anxiolytic properties and uses thereof |
| 03/22/2001 | WO2000060066A8 Protein-protein from s. cerevisiae and methods of using same |
| 03/22/2001 | WO2000056808A3 Surface and its manufacture and uses |
| 03/22/2001 | WO2000049177A3 HIGH DENSITY SAMPLING OF DIFFERENTIALLY EXPRESSED PROKARYOTIC mRNA |
| 03/22/2001 | WO2000045840A8 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
| 03/22/2001 | WO2000018421A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 03/22/2001 | WO2000001799A3 Method of preventing bacteriophage infection of bacterial cultures |
| 03/22/2001 | DE19944142A1 Rapid culture of the unicellular alga Euglena gracilis useful producing a paramylon reserve carbohydrate, useful in pharmaceutical and cosmetics industries comprises culturing in a medium containing waste yeast from the brewing industry |
| 03/22/2001 | DE19943919A1 Verfahren zur Steigerung der Ausbeute von rekombinanten Proteinen in mikrobiellen Fermentationsprozessen A method for increasing the yield of recombinant proteins in microbial fermentation processes |
| 03/22/2001 | CA2386530A1 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | CA2385241A1 Micro-organisms, their use and method for producing d-amino acids |
| 03/22/2001 | CA2384990A1 System and method for microwave cell lysing of small samples |